Jeffrey H Lipton

Jeffrey H Lipton, PhD, MD, FRCPC

I am involved in clinical research at the phase I, II and III levels on the therapy of chronic myeloid leukemia. This involves targeted therapy with kinase inhibitors, drugs that may target the CML stem cell and cells that are resistant to other therapies. The interest in targeted therapy extends into the phase II study of signal transduction inhibitors in the therapy of other diseases such as systemic mastocytosis and mast cell leukemia.

The second aspect of my clinical research involves outcome analysis in allogeneic stem cell transplant and the prevention and therapy of side effects. I am particularly interested in donor selection, graft types and therapy of chronic side effects. I am also interested in long term effects on patients who are out beyond the initial post transplant period.
Pediatrics. 2017 Oct 30;:
Shearer WT, Lubin BH, Cairo MS, Notarangelo LD, SECTION ON HEMATOLOGY/ONCOLOGY, SECTION ON ALLERGY AND IMMUNOLOGY
Cancer. 2017 Oct 26;:
Kantarjian HM, Mamolo CM, Gambacorti-Passerini C, Cortes JE, Brümmendorf TH, Su Y, Reisman AL, Shapiro M, Lipton JH
Clin Genet. 2017 Oct 16;:
Arbiv OA, Cuvelier G, Klaassen RJ, Fernandez CV, Robitaille N, Steele MG, Breakey V, Abish S, Wu J, Sinha R, Silva M, Goodyear L, Jardine L, Lipton JH, Corriveau-Bourque C, Brossard J, Michon B, Ghemlas I, Waespe N, Zlateska B, Sung L, Cada M, Dror Y
Biol Blood Marrow Transplant. 2017 Oct 03;:
Beswick J, Shin E, Michelis F, Thyagu S, Viswabandya A, Lipton JH, Messner H, Marras TK, Kim D
Br J Haematol. 2017 Oct 04;:
Kharfan-Dabaja MA, Al Malki MM, Deotare U, Raj RV, El-Jurdi N, Majhail N, Cherry MA, Bashir Q, Darrah J, Nishihori T, Sibai H, Hamadani M, de Lima M, Gerds AT, Selby G, Qazilbash MH, Forman SJ, Ayala E, Lipton JH, Hari PN, Muzzafar T, Zhang L, Olteanu...
Leukemia. 2017 Aug 03;:
Hughes TP, Leber B, Cervantes F, Spector N, Pasquini R, Clementino NCD, Schwarer AP, Dorlhiac-Llacer PE, Mahon FX, Rea D, Guerci-Bresler A, Kamel-Reid S, Bendit I, Acharya S, Glynos T, Dalal D, Branford S, Lipton JH
Clin Lymphoma Myeloma Leuk. 2017 Jun 17;:
Cortes JE, Gambacorti-Passerini C, Kim DW, Kantarjian HM, Lipton JH, Lahoti A, Talpaz M, Matczak E, Barry E, Leip E, Brümmendorf TH, Khoury HJ
Clin Lymphoma Myeloma Leuk. 2017 Jul 15;:
Aghel N, Lipton JH, Atenafu EG, Kim DDH, Delgado DH
Br J Haematol. 2017 Jul 12;:
Hughes TP, Munhoz E, Aurelio Salvino M, Ong TC, Elhaddad A, Shortt J, Quach H, Pavlovsky C, Louw VJ, Shih LY, Turkina AG, Meillon L, Jin Y, Acharya S, Dalal D, Lipton JH

Pages


 

Professor of Medicine, University of Toronto